• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Endoscopic mesorectal dissection for precise rectal cancer staging: trespassing the boundaries of lumenal rectal interventions.

作者信息

Emura Fabian, Hernandez-Dinas Diego, Petano-Romero Francisco, Rodriguez-Reyes Carlos, Donneys Alberto, Huertas Sandra, Sabbagh Luis, Calderón-Zapata Douvan

机构信息

Digestive Health and Liver Diseases, Miller School of Medicine, University of Miami, Coral Gables, FL, USA.

Interventional Endoscopy Center, Jackson Memorial Hospital, Miami, FL, USA.

出版信息

VideoGIE. 2024 Oct 25;10(3):187-190. doi: 10.1016/j.vgie.2024.10.012. eCollection 2025 Mar.

DOI:10.1016/j.vgie.2024.10.012
PMID:40093294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11910318/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/477f/11910318/556ab0cec5ee/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/477f/11910318/2d6d7489836c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/477f/11910318/f54936f52b89/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/477f/11910318/28e468e01fc4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/477f/11910318/5723258463cc/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/477f/11910318/556ab0cec5ee/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/477f/11910318/2d6d7489836c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/477f/11910318/f54936f52b89/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/477f/11910318/28e468e01fc4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/477f/11910318/5723258463cc/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/477f/11910318/556ab0cec5ee/gr5.jpg

相似文献

1
Endoscopic mesorectal dissection for precise rectal cancer staging: trespassing the boundaries of lumenal rectal interventions.用于精确直肠癌分期的内镜下直肠系膜剥离术：突破腔内直肠干预的界限
VideoGIE. 2024 Oct 25;10(3):187-190. doi: 10.1016/j.vgie.2024.10.012. eCollection 2025 Mar.
2
Distinctive features of small vessels on the mesorectal and parietal pelvic fascia as important landmarks in guiding precise inter-fascial dissection for low rectal cancer.直肠系膜和盆壁筋膜中小血管的特征是指导低位直肠癌精确筋膜间解剖的重要标志。
Surg Endosc. 2022 Feb;36(2):1657-1665. doi: 10.1007/s00464-021-08683-9. Epub 2021 Aug 16.
3
Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.中低位直肠癌行直肠系膜切除术联合或不联合侧方淋巴结清扫的术后发病率和死亡率（JCOG0212）：来自一项多中心、随机对照、非劣效性试验的结果。
Lancet Oncol. 2012 Jun;13(6):616-21. doi: 10.1016/S1470-2045(12)70158-4. Epub 2012 May 15.
4
Early Experience With Transanal Total Mesorectal Excision Compared With Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Propensity Score-Matched Analysis.经肛门全直肠系膜切除术与腹腔镜全直肠系膜切除术治疗直肠癌的早期经验比较：倾向评分匹配分析。
Dis Colon Rectum. 2020 Nov;63(11):1500-1510. doi: 10.1097/DCR.0000000000001725.
5
Mesorectal excision with or without lateral lymph node dissection for elderly patients with mid-low rectal cancer: safety and feasibility analysis.老年中低位直肠癌患者行或不行侧方淋巴结清扫的直肠系膜切除术：安全性与可行性分析
Jpn J Clin Oncol. 2023 Jan 6;53(1):26-34. doi: 10.1093/jjco/hyac167.
6
Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer After Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome.经术前放化疗后 ypT0-1 期直肠腺癌患者行经肛门内镜微创手术与全直肠系膜切除术的对比：术后并发症、功能结果和长期肿瘤学转归。
Dis Colon Rectum. 2022 Nov 1;65(11):1306-1315. doi: 10.1097/DCR.0000000000002255. Epub 2022 Jan 20.
7
Urinary dysfunction after rectal cancer surgery: Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG0212).直肠癌手术后的尿功能障碍：中直肠切除加与不加侧方淋巴结清扫治疗临床 II 期或 III 期低位直肠癌的随机试验结果（日本临床肿瘤学组研究，JCOG0212）。
Eur J Surg Oncol. 2018 Apr;44(4):463-468. doi: 10.1016/j.ejso.2018.01.015. Epub 2018 Jan 17.
8
Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study.根治性手术与短程放疗联合经肛门内镜微创手术保肛治疗早期直肠癌（TREC）：一项随机、开放标签可行性研究。
Lancet Gastroenterol Hepatol. 2021 Feb;6(2):92-105. doi: 10.1016/S2468-1253(20)30333-2. Epub 2020 Dec 11.
9
Phase II Clinical Trial to Evaluate the Efficacy of Transanal Endoscopic Total Mesorectal Excision for Rectal Cancer.二期临床试验评估经肛门内镜微创手术治疗直肠癌的疗效。
Dis Colon Rectum. 2018 May;61(5):554-560. doi: 10.1097/DCR.0000000000001058.
10
Transanal Total Mesorectal Excision: Pneumodissection of Retroperitoneal Structures Eases Laparoscopic Rectal Resection.经肛门全直肠系膜切除术：腹膜后结构的气体分离术可简化腹腔镜直肠切除术。
Dis Colon Rectum. 2017 Oct;60(10):1109-1112. doi: 10.1097/DCR.0000000000000893.

本文引用的文献

1
NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024.NCCN 指南®洞察：直肠癌，第 3.2024 版。
J Natl Compr Canc Netw. 2024 Aug;22(6):366-375. doi: 10.6004/jnccn.2024.0041.
2
Short-term outcomes of chemoradiotherapy and local excision versus total mesorectal excision in T2-T3ab,N0,M0 rectal cancer: a multicentre randomised, controlled, phase III trial (the TAU-TEM study).T2-T3ab、N0、M0期直肠癌放化疗联合局部切除与全直肠系膜切除的短期疗效比较：一项多中心随机对照III期试验（TAU-TEM研究）
Ann Oncol. 2023 Jan;34(1):78-90. doi: 10.1016/j.annonc.2022.09.160. Epub 2022 Oct 8.
3
Technical feasibility of salvage endoscopic submucosal dissection after chemoradiation for locally advanced rectal adenocarcinoma.
局部进展期直肠腺癌放化疗后挽救性内镜黏膜下剥离术的技术可行性。
Gastrointest Endosc. 2022 Aug;96(2):359-367. doi: 10.1016/j.gie.2022.02.014. Epub 2022 Feb 17.
4
Prior endoscopic resection does not affect the outcome of secondary surgery for T1 colorectal cancer, a systematic review and meta-analysis.内镜切除术前是否会影响 T1 结直肠癌的二次手术结果：系统评价和荟萃分析。
Int J Colorectal Dis. 2022 Feb;37(2):273-281. doi: 10.1007/s00384-021-04049-8. Epub 2021 Oct 30.
5
Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study.根治性手术与短程放疗联合经肛门内镜微创手术保肛治疗早期直肠癌（TREC）：一项随机、开放标签可行性研究。
Lancet Gastroenterol Hepatol. 2021 Feb;6(2):92-105. doi: 10.1016/S2468-1253(20)30333-2. Epub 2020 Dec 11.
6
Lymph Node Positivity in T1/T2 Rectal Cancer: a Word of Caution in an Era of Increased Incidence and Changing Biology for Rectal Cancer.T1/T2 期直肠癌的淋巴结阳性率：直肠癌发病率上升和生物学特性改变时代的一个警示。
J Gastrointest Surg. 2021 Apr;25(4):1029-1035. doi: 10.1007/s11605-020-04580-z. Epub 2020 Apr 3.
7
Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.直肠癌的放化疗联合局部切除保肛治疗：GRECCAR 2 随机试验的 5 年结果。
Lancet Gastroenterol Hepatol. 2020 May;5(5):465-474. doi: 10.1016/S2468-1253(19)30410-8. Epub 2020 Feb 7.
8
Transanal endoscopic microsurgery for rectal cancer: T1 and beyond? An evidence-based review.经肛门内镜显微手术治疗直肠癌：T1期及更晚期？循证综述
Surg Endosc. 2016 Nov;30(11):4841-4852. doi: 10.1007/s00464-016-4818-9. Epub 2016 Feb 22.
9
Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.使用新辅助放化疗和局部切除对临床T2N0期低位直肠癌进行器官保留（ACOSOG Z6041）：一项开放标签、单臂、多机构的2期试验结果
Lancet Oncol. 2015 Nov;16(15):1537-1546. doi: 10.1016/S1470-2045(15)00215-6. Epub 2015 Oct 22.
10
Evaluating local lymph node metastasis with magnetic resonance imaging, endoluminal ultrasound and computed tomography in rectal cancer: a meta-analysis.磁共振成像、腔内超声和计算机断层扫描评估直肠癌局部淋巴结转移的Meta分析
Colorectal Dis. 2015 Jun;17(6):O129-35. doi: 10.1111/codi.12909.